TIPE1 and bladder transitional cell carcinoma: TIPE1 expression did not differ between the invasive BRCA group (n = 1,085) and normal group (n = 291, p > 0.05), nor between the urothelial bladder carcinoma (BLCA) group (n = 404) and normal group (n = 28, p > 0.05) or liver hepatocellular carcinoma (LIHC) group (n = 369) and normal group (n = 160, p > 0.05).